BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 18160456)

  • 1. Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.
    Persat F; Ranque S; Derouin F; Michel-Nguyen A; Picot S; Sulahian A
    J Clin Microbiol; 2008 Mar; 46(3):1009-13. PubMed ID: 18160456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia.
    Senn L; Robinson JO; Schmidt S; Knaup M; Asahi N; Satomura S; Matsuura S; Duvoisin B; Bille J; Calandra T; Marchetti O
    Clin Infect Dis; 2008 Mar; 46(6):878-85. PubMed ID: 18260755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.
    Pini P; Bettua C; Orsi CF; Venturelli C; Forghieri F; Bigliardi S; Faglioni L; Luppi F; Serio L; Codeluppi M; Luppi M; Mussini C; Girardis M; Blasi E
    Infection; 2016 Apr; 44(2):223-33. PubMed ID: 26475482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.
    Pickering JW; Sant HW; Bowles CA; Roberts WL; Woods GL
    J Clin Microbiol; 2005 Dec; 43(12):5957-62. PubMed ID: 16333082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis.
    Onishi A; Sugiyama D; Kogata Y; Saegusa J; Sugimoto T; Kawano S; Morinobu A; Nishimura K; Kumagai S
    J Clin Microbiol; 2012 Jan; 50(1):7-15. PubMed ID: 22075593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].
    Rácil Z; Kocmanová I; Weinbergerová B; Winterová J; Lengerová M; Hrncírová K; Mayer J
    Klin Mikrobiol Infekc Lek; 2009 Apr; 15(2):48-57. PubMed ID: 19488961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The (1,3){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation.
    Alexander BD; Smith PB; Davis RD; Perfect JR; Reller LB
    J Clin Microbiol; 2010 Nov; 48(11):4083-8. PubMed ID: 20720025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of bronchoalveolar lavage beta-D-glucan testing for the diagnosis of invasive fungal infections.
    Rose SR; Vallabhajosyula S; Velez MG; Fedorko DP; VanRaden MJ; Gea-Banacloche JC; Lionakis MS
    J Infect; 2014 Sep; 69(3):278-83. PubMed ID: 24797077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparable Serum and Plasma 1,3-β-d-Glucan Values Obtained Using the Wako β-Glucan Test in Patients with Probable or Proven Fungal Diseases.
    De Carolis E; Marchionni F; Torelli R; Posteraro P; De Pascale G; Carelli S; Sanguinetti M; Posteraro B
    J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30842228
    [No Abstract]   [Full Text] [Related]  

  • 10. Retrospective assessment of β-D-(1,3)-glucan for presumptive diagnosis of fungal infections.
    Bellanger AP; Grenouillet F; Henon T; Skana F; Legrand F; Deconinck E; Millon L
    APMIS; 2011 Apr; 119(4-5):280-6. PubMed ID: 21492228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome.
    Odabasi Z; Mattiuzzi G; Estey E; Kantarjian H; Saeki F; Ridge RJ; Ketchum PA; Finkelman MA; Rex JH; Ostrosky-Zeichner L
    Clin Infect Dis; 2004 Jul; 39(2):199-205. PubMed ID: 15307029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The diagnostic value of detecting plasma 1, 3-beta-D-glucan for invasive fungal infections].
    Lü PH; Zhao BL; Shi Y; Wen YT
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jan; 30(1):31-4. PubMed ID: 17326970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3).
    Lamoth F; Cruciani M; Mengoli C; Castagnola E; Lortholary O; Richardson M; Marchetti O;
    Clin Infect Dis; 2012 Mar; 54(5):633-43. PubMed ID: 22198786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia.
    White PL; Price JS; Posso RB; Barnes RA
    Med Mycol; 2017 Nov; 55(8):843-850. PubMed ID: 28340117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of biomarkers: Galactomannan and 1,3-beta-D-glucan assay for the diagnosis of invasive fungal infections in immunocompromised patients from a tertiary care centre.
    Singh S; Kaur H; Choudhary H; Sethi S; Malhotra P; Gupta KL; Rudramurthy SM; Chakrabarti A
    Indian J Med Microbiol; 2018; 36(4):557-563. PubMed ID: 30880706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Values and Limitations of (1,3)-β-D-Glucans and Galactomannan Assays for Invasive Fungal Infection in Patients Admitted to Pediatric Intensive Care Unit.
    Zheng F; Zha H; Yang D; Deng J; Zhang Z
    Mycopathologia; 2017 Apr; 182(3-4):331-338. PubMed ID: 27664106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the clinical utility of serial beta-D-glucan concentrations in patients with persistent neutropenic fever.
    Ellis M; Al-Ramadi B; Finkelman M; Hedstrom U; Kristensen J; Ali-Zadeh H; Klingspor L
    J Med Microbiol; 2008 Mar; 57(Pt 3):287-295. PubMed ID: 18287290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of (1,3)-β-d-Glucan for the Diagnosis of Invasive Fungal Infection in Liver Transplant Recipients.
    Levesque E; Rizk F; Noorah Z; Aït-Ammar N; Cordonnier-Jourdin C; El Anbassi S; Bonnal C; Azoulay D; Merle JC; Botterel F
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28422065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic value of plasma (1, 3)-beta-D glucan assay for invasive fungal infections in patients with hematological disorders].
    Liu F; Wu T; Cai P; Liu Y; Lu Y; Zhou JR; Yang F; Liu Q; Gao YQ; Luo RM; Zhang JP; Sun Y; Cao XY; Yin YM; Zhao YL; Wang JB; Tong CR; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):1043-6. PubMed ID: 19698256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.
    Ostrosky-Zeichner L; Alexander BD; Kett DH; Vazquez J; Pappas PG; Saeki F; Ketchum PA; Wingard J; Schiff R; Tamura H; Finkelman MA; Rex JH
    Clin Infect Dis; 2005 Sep; 41(5):654-9. PubMed ID: 16080087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.